This inventor holds 4 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Bayer Intellectual Property Gmbh, Bayer IP Gmbh. Active years: 2013-2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013-2017
Title: Innovations by Inventor Stephan Mletzko
Introduction
Stephan Mletzko is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceutical formulations, particularly in hormone replacement therapy and transdermal therapeutic systems. With a total of 4 patents to his name, Mletzko's work has the potential to improve the quality of life for many individuals.
Latest Patents
One of Mletzko's latest patents is focused on very low-dosed solid oral dosage forms for hormone replacement therapy (HRT). This invention relates to a solid oral dosage form that comprises about 0.5 mg estradiol and about 0.25 mg drospirenone, along with at least one pharmaceutically acceptable excipient. Remarkably, despite the low doses, a significant number of women suffering from moderate to severe hot flushes have been found to respond positively to this treatment. This dosage form can be utilized as maintenance HRT or initiated at the start of HRT.
Another significant patent by Mletzko is a UV stable transdermal therapeutic plaster with a UV absorbing self-adhesive layer separated from the drug matrix. This invention consists of a back layer, at least one matrix containing an active substance, and an adhesive layer that includes a UV-radiation absorber. The design ensures that the adhesive layer is positioned as far as possible from the surface, enhancing the stability of the therapeutic system and eliminating the issues associated with existing light-sensitive substances.
Career Highlights
Throughout his career, Mletzko has worked with prominent companies such as Bayer Intellectual Property GmbH and Bayer IP GmbH. His experience in these organizations has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.
Collaborations
Mletzko has collaborated with notable professionals in his field, including Manfred Suesse and Michael Dittgen. These collaborations have likely contributed to the advancement of his inventions and the successful development of his patents.
Conclusion
Stephan Mletzko's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to improving healthcare solutions. His work in hormone replacement therapy and transdermal systems showcases the potential for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile